We are live on ! Find out more
LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
1-Year Est. Return 30.74%
This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
-30.74%
3 Year Est. Return
+54.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.5M
AUM Growth
-$61.2M
Cap. Flow
-$74.7M
Cap. Flow %
-81.61%
Top 10 Hldgs %
97.26%
Holding
22
New
7
Increased
2
Reduced
3
Closed
10

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$11.4M
2
NMBL
Nimble Storage, Inc.
NMBL
+$8.76M
3
AMGN icon
Amgen
AMGN
+$7.5M
4
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
+$6.18M
5
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$4.08M

Top Sells

Rank Stock Value
1
BLOX
Infoblox Inc
BLOX
+$22.9M
2
KITE
Kite Pharma, Inc.
KITE
+$17.5M
3
BLUE
bluebird bio
BLUE
+$13.5M
4
RALY
RALLY SOFTWARE DEV CORP
RALY
+$13.2M
5
OREX
Orexigen Therapeutics, Inc.
OREX
+$11.5M

Sector Composition

Rank Sector Weight
1 Healthcare 58.47%
2 Technology 28.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$1.86B
$17.6M 19.28%
420,243
+345,863
+465% +$11.4M
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15.6M 17.08%
171,496
+37,266
+28% +$3.03M
GILD icon
3
Gilead Sciences
GILD
$161B
$11.8M 12.87%
120,000
-15,870
-12% -$1.61M
BLOX
4
DELISTED
Infoblox Inc
BLOX
$10.3M 11.21%
429,922
-1,065,984
-71% -$22.9M
NMBL
5
DELISTED
Nimble Storage, Inc.
NMBL
$8.03M 8.78%
+360,100
New +$8.76M
AMGN icon
6
Amgen
AMGN
$203B
$7.61M 8.31%
+47,590
New +$7.5M
KITE
7
DELISTED
Kite Pharma, Inc.
KITE
$6.01M 6.57%
104,250
-261,650
-72% -$17.5M
TRAK
8
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$5.86M 6.4%
+151,990
New +$6.18M
ZNGA
9
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$4.5M 4.92%
+1,580,770
New +$4.08M
VMEM
10
DELISTED
VIOLIN MEMORY, INC.
VMEM
$1.69M 1.85%
+112,025
New +$1.79M
KING
11
DELISTED
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
$1.65M 1.8%
+102,720
New +$1.48M
BLCM
12
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$857K 0.94%
+3,700
New +$895K
BLUE
13
DELISTED
bluebird bio
BLUE
– –
-11,378
Closed -$13.5M
BMRN icon
14
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-91,840
Closed -$8.3M
CRM icon
15
Salesforce
CRM
$134B
– –
-127,970
Closed -$7.59M
PBYI icon
16
Puma Biotechnology
PBYI
$406M
– –
-55,005
Closed -$10.4M
RARE icon
17
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-77,940
Closed -$3.42M
RNG icon
18
RingCentral
RNG
$4.05B
– –
-161,424
Closed -$2.41M
RALY
19
DELISTED
RALLY SOFTWARE DEV CORP
RALY
– –
-1,163,626
Closed -$13.2M
AOL
20
DELISTED
AOL INC COMMON STOCK
AOL
– –
-128,850
Closed -$5.95M
GEVA
21
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-15,390
Closed -$1.43M
OREX
22
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-189,100
Closed -$11.5M

Similar funds

HCM
Hirzel Capital Management Dallas, Texas $15.1M AUM 5.29% 1-Year Est. Return
PPF
PartnerRe Principal Finance Greenwich, Connecticut $15.5M AUM 13.01% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
TSU
TD Securities (USA) New York $11M AUM 2.35% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
SCA
Strategic Capital Alternatives Gig Harbor, United States $6.3M AUM
GFWEV
G.F.W. Energy VII Irving, Texas $1.49M AUM 89.53% 1-Year Est. Return
STA
System Two Advisors Summit, New Jersey $23K AUM 23.64% 1-Year Est. Return

Lamond Capital Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Lamond Capital Partners held 22 positions worth $91.5M, down 40% from $153M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Lamond Capital Partners withdrew a net $74.7M in Q1 2015, closing 10 positions and reducing 3 holdings. Its most notable exit was bluebird bio, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 46% a quarter earlier, followed by Technology.

Against the trend, Lamond Capital Partners opened a new position in Nimble Storage, Inc. worth $8.03M.

  • Lamond Capital Partners's largest Q1 2015 buy was Nimble Storage, Inc.: 360,100 shares worth $8.03M.
  • Lamond Capital Partners added most to Ocular Therapeutix in Q1 2015, an estimated $11.4M increase.
  • Lamond Capital Partners's biggest Q1 2015 reduction was Infoblox Inc, cutting an estimated $22.9M.
  • Lamond Capital Partners fully exited bluebird bio in Q1 2015, selling an estimated $13.5M.
  • Lamond Capital Partners's ten largest holdings make up 97% of its $91.5M portfolio in Q1 2015.
  • Lamond Capital Partners opened 7 new positions and closed 10 in Q1 2015.
  • Lamond Capital Partners's portfolio value fell 40% quarter-over-quarter to $91.5M.

Based on Lamond Capital Partners's 13F filing for Q1 2015, filed 12 May 2015.